NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
scientific article published on 10 March 2020
Author/s
author: Eudocia Q Lee, David A Reardon, Edward Pan, John L Villano, Patrick Y Wen, Jeffrey J. Raizer, Kenneth D Aldape, Elizabeth R. Gerstner, Lyndon J. Kim, Steven J Chmura, James D Battiste, Naveed Wagle, Ryan T Merrell, Merideth M Wendland, Minesh Mehta
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.